7月2日，Argenx SE盘中上涨3.02%，报935.745美元/股，成交额4630.24万美元。
Argenx SE所在的生物科技行业中，整体表现偏强，个股中，Moderna涨10.69%，Abivax S.A.涨8.97%，艾伯维公司涨1.43%，福泰制药涨3.21%，Propanc Biopharma涨42.36%。
Argenx SE是一家处于商业阶段的全球性生物制药公司，核心产品Vyvgart用于治疗严重自身免疫性疾病，目前已获批用于全血清型广泛性重症肌无力及慢性炎症性脱髓鞘多神经病变等适应症。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.